C7B
Secondary neuroendocrine tumors
Codes in this block
10 codes
Billableusable codeNon-billableheader / grouping codeRisk-adjusting
- C7BSecondary neuroendocrine tumorsNon-billable
- C7B.0Secondary carcinoid tumorsNon-billable
- C7B.00Secondary carcinoid tumors, unspecified siteBillable
- C7B.01Secondary carcinoid tumors of distant lymph nodesBillable
- C7B.02Secondary carcinoid tumors of liverBillable
- C7B.03Secondary carcinoid tumors of boneBillable
- C7B.04Secondary carcinoid tumors of peritoneumBillable
- C7B.09Secondary carcinoid tumors of other sitesBillable
- C7B.1Secondary Merkel cell carcinomaBillable
- C7B.8Other secondary neuroendocrine tumorsBillable
Official Guidelines for C7B
FY 2026 ›I.C.2Chapter-specific guidanceChapter 2: Neoplasms (C00-D49)
Subsections
- I.C.2.aAdmission/Encounter for treatment of primary site
- I.C.2.bAdmission/Encounter for treatment of secondary site
- I.C.2.cCoding and sequencing of complications
- I.C.2.dPrimary malignancy previously excised
- I.C.2.eAdmissions/Encounters involving antineoplastic chemotherapy, immunotherapy and radiation therapy
- I.C.2.fAdmission/encounter to determine extent of malignancy
- I.C.2.gSymptoms, signs, and abnormal findings listed in Chapter 18 associated with neoplasms
- I.C.2.hAdmission/encounter for pain control/management
- I.C.2.iMalignancy in two or more noncontiguous sites
- I.C.2.jDisseminated malignant neoplasm, unspecified
- I.C.2.kMalignant neoplasm without specification of site
- I.C.2.lSequencing of neoplasm codes
- I.C.2.mCurrent malignancy versus personal history of malignancy
- I.C.2.nLeukemia, Multiple Myeloma, and Malignant Plasma Cell
- I.C.2.oAftercare following surgery for neoplasm
- I.C.2.pFollow-up care for completed treatment of a malignancy
- I.C.2.qProphylactic organ removal for prevention of malignancy
- I.C.2.rMalignant neoplasm associated with transplanted organ
- I.C.2.sBreast Implant Associated Anaplastic Large Cell Lymphoma
- I.C.2.tSecondary malignant neoplasm of lymphoid tissue